The goal of this training program is to provide laboratory research training for physician (M.D. and M.D./Ph.D.) and Ph.D. postdoctoral scientists in vascular biology, in preparation for careers as independent investigators in blood vessel biology-related disciplines. Selection of trainees will be based on a demonstrated commitment to vascular biology and strong prior research experience or potential of same. Future physician-scientists are major targets for this training program. Three years of support, per trainee, are requested, for three postdoctoral fellows in the first year of the program. The Molecular Cardiobiology Unit at Yale School of Medicine's Boyer Center for Molecular Medicine, and the Cardiovascular Medicine Division of Internal Medicine, will be the central foundations for the Program. However, because vascular biology pervades wide areas of clinical medicine and basic biologic research, the program will interact with multiple clinical and basic science departments. Testimonies to that are the departmental affiliations of the primary participating faculty, which include Internal Medicine (Pulmonary and Cardiovascular Medicine), Pathology, Genetics, Immunobiology, Physiology and Biology. The interdepartmental vascular research community at Yale will coalesce through this training program and provide research opportunities in the following area: 1) molecular determinants and consequences of leukocyte-endothelial cell interactions: 2) regulation of vascular apoptotic and anti-apoptotic signals; 3) effects of coagulation proteins on vascular cell activation and injury; 4) the role of cytokines and membrane receptors in anti-endothelial alloresponses; 5) in vivo vascular gene delivery in allo- and xenograft models; 6) regulation of cytoprotective genes in vascular cells in response to hypoxia; 7) use of genetic methods to evaluate G protein-mediated signal transduction in eukaryotes; 8) vascular cell integrin biology, both control of adhesion and molecular consequences of engagement; 9) use of chemical genetic approaches to study anti-angiogenic compounds; 10) identification and mapping of genes that contribute to the development of vascular disease in humans, through molecular genetic techniques; 11) microcirculatory analysis of neurohumoral and cell coupling mechanisms which control vasomotion; and 12) regulation of endothelial nitric oxide release in normal physiology and disease. This broad base of vascular research underscores the strength and breadth of vascular biology at the Yale School of Medicine, and highlights the numerous research opportunities for postdoctoral trainees. A strong educational curriculum will be provided, including didactic courses specifically for postdoctoral fellows, courses within the graduate school, as well as both program-based and multi departmental research seminars and journal clubs. Progress will be monitored through several mechanisms, including individual trainee progress committees.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007950-02
Application #
6343482
Study Section
Special Emphasis Panel (ZHL1-CSR-K (F1))
Program Officer
Schucker, Beth
Project Start
2000-08-01
Project End
2006-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
2
Fiscal Year
2002
Total Cost
$283,322
Indirect Cost
Name
Yale University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Zhang, Feng; Zarkada, Georgia; Han, Jinah et al. (2018) Lacteal junction zippering protects against diet-induced obesity. Science 361:599-603
Sheikh, Abdul Q; Saddouk, Fatima Zahra; Ntokou, Aglaia et al. (2018) Cell Autonomous and Non-cell Autonomous Regulation of SMC Progenitors in Pulmonary Hypertension. Cell Rep 23:1152-1165
Ceneri, Nicolle; Zhao, Lina; Young, Bryan D et al. (2017) Rac2 Modulates Atherosclerotic Calcification by Regulating Macrophage Interleukin-1? Production. Arterioscler Thromb Vasc Biol 37:328-340
Mazurek, R; Dave, J M; Chandran, R R et al. (2017) Vascular Cells in Blood Vessel Wall Development and Disease. Adv Pharmacol 78:323-350
Ola, Roxana; Dubrac, Alexandre; Han, Jinah et al. (2016) PI3 kinase inhibition improves vascular malformations in mouse models of hereditary haemorrhagic telangiectasia. Nat Commun 7:13650
Padmanabhan, Jagannath; Augelli, Michael J; Cheung, Bettina et al. (2016) Regulation of cell-cell fusion by nanotopography. Sci Rep 6:33277
Sawyer, Andrew J; Kyriakides, Themis R (2016) Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localization. Adv Drug Deliv Rev 97:56-68
Lee, Seung Hee; Du, Jing; Stitham, Jeremiah et al. (2016) Inducing mitophagy in diabetic platelets protects against severe oxidative stress. EMBO Mol Med 8:779-95
Moore, Laura Beth; Sawyer, Andrew J; Saucier-Sawyer, Jennifer et al. (2016) Nanoparticle delivery of miR-223 to attenuate macrophage fusion. Biomaterials 89:127-35
Marin, Ethan P; Jozsef, Levente; Di Lorenzo, Annarita et al. (2016) The Protein Acyl Transferase ZDHHC21 Modulates ?1 Adrenergic Receptor Function and Regulates Hemodynamics. Arterioscler Thromb Vasc Biol 36:370-9

Showing the most recent 10 out of 60 publications